Biovie Inc Stock Price Prediction
| BIVI Stock | USD 0.49 0.01 2.08% |
Oversold Vs Overbought
33
Oversold | Overbought |
Biovie Inc stock price prediction is an act of determining the future value of Biovie shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Biovie's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Biovie and does not consider all of the tangible or intangible factors available from Biovie's fundamental data. We analyze noise-free headlines and recent hype associated with Biovie Inc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Biovie's stock price prediction:EPS Estimate Next Quarter (0.33) | EPS Estimate Current Year (1.28) | EPS Estimate Next Year (1.30) | Wall Street Target Price 11 | EPS Estimate Current Quarter (0.32) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Biovie based on different types of headlines from major news networks to social media. The Biovie stock price prediction module provides an analysis of price elasticity to changes in media outlook on Biovie over a specific investment horizon. Using Biovie hype-based prediction, you can estimate the value of Biovie Inc from the perspective of Biovie response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Biovie. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Biovie to buy its stock at a price that has no basis in reality. In that case, they are not buying Biovie because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Biovie after-hype prediction price | USD 0.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biovie |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biovie's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biovie After-Hype Price Prediction Density Analysis
As far as predicting the price of Biovie at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biovie or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biovie, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biovie Estimiated After-Hype Price Volatility
In the context of predicting Biovie's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biovie's historical news coverage. Biovie's after-hype downside and upside margins for the prediction period are 0.02 and 10.46, respectively. We have considered Biovie's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biovie is dangerous at this time. Analysis and calculation of next after-hype price of Biovie Inc is based on 3 months time horizon.
Biovie Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Biovie is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biovie backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biovie, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.54 | 10.05 | 0.01 | 0.01 | 4 Events / Month | 6 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.49 | 0.48 | 2.04 |
|
Biovie Hype Timeline
Biovie Inc is currently traded for 0.49. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. Biovie is anticipated to decline in value after the next headline, with the price expected to drop to 0.48. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.04%, whereas the daily expected return is currently at -0.54%. The volatility of related hype on Biovie is about 90450.0%, with the expected price after the next announcement by competition of 0.48. About 43.0% of the company shares are held by company insiders. The book value of Biovie was currently reported as 0.19. The company recorded a loss per share of 1.17. Biovie Inc last dividend was issued on the 22nd of November 2019. The entity had 1:125 split on the 22nd of November 2019. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days. Check out Biovie Basic Forecasting Models to cross-verify your projections.Biovie Related Hype Analysis
Having access to credible news sources related to Biovie's direct competition is more important than ever and may enhance your ability to predict Biovie's future price movements. Getting to know how Biovie's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biovie may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INZY | Inozyme PharmaInc | (0.35) | 8 per month | 4.45 | 0.02 | 8.83 | (8.42) | 25.32 | |
| DAWN | Day One Biopharmaceuticals | 0.40 | 9 per month | 3.46 | 0.04 | 5.49 | (5.02) | 20.03 | |
| TERN | Terns Pharmaceuticals | (0.75) | 8 per month | 5.33 | (0.01) | 8.64 | (8.38) | 27.76 | |
| ELDN | Eledon Pharmaceuticals | 0.22 | 5 per month | 3.92 | 0.07 | 6.91 | (5.78) | 33.28 | |
| HOOK | Hookipa Pharma | (0.02) | 8 per month | 3.16 | 0.02 | 6.25 | (6.17) | 24.40 | |
| XFOR | X4 Pharmaceuticals | 0.28 | 8 per month | 4.18 | 0.16 | 10.47 | (7.00) | 37.52 | |
| ABOS | Acumen Pharmaceuticals | 0.1 | 7 per month | 0.00 | (0.06) | 7.28 | (6.35) | 23.58 | |
| MREO | Mereo BioPharma Group | (0.02) | 8 per month | 0.00 | (0.03) | 7.69 | (6.07) | 21.23 | |
| AMLX | Amylyx Pharmaceuticals | 0.04 | 7 per month | 0.00 | (0.15) | 6.96 | (8.30) | 103.39 |
Biovie Additional Predictive Modules
Most predictive techniques to examine Biovie price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biovie using various technical indicators. When you analyze Biovie charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biovie Predictive Indicators
The successful prediction of Biovie stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biovie Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biovie based on analysis of Biovie hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biovie's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biovie's related companies. Story Coverage note for Biovie
The number of cover stories for Biovie depends on current market conditions and Biovie's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biovie is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biovie's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Biovie Short Properties
Biovie's future price predictability will typically decrease when Biovie's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biovie Inc often depends not only on the future outlook of the potential Biovie's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biovie's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.5 M | |
| Cash And Short Term Investments | 33.9 M |
Check out Biovie Basic Forecasting Models to cross-verify your projections. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Biovie Stock analysis
When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Biovie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Return On Assets (0.81) | Return On Equity (2.58) |
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.